Aldose reductase (AR) inhibition provides a viable pharmacologically direct
mode for the treatment of diabetic complications. We have synthesized a se
ries of N-4 substituted analogues (15-21) of the known aldose reductase inh
ibitor phenyl-sulfonylnitromethane. The compounds are potent inhibitors of
AR with IC(50)s between 0.01 and 0.19 mu M Some of the compounds are also p
otent affinity labels for AR. Compound 19 exhibits the highest and almost c
omplete irreversible inhibition of AR known to date. (C) 1999 Editions scie
ntifiques et medicales Elsevier SAS.